Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

DV Biomed Co., Ltd. (6539.TWO)

Compare
62.00
-0.10
(-0.16%)
As of 11:59:55 AM GMT+8. Market Open.
Loading Chart for 6539.TWO
  • Previous Close 62.10
  • Open 62.00
  • Bid 62.00 x --
  • Ask 64.00 x --
  • Day's Range 62.00 - 64.00
  • 52 Week Range 57.80 - 153.57
  • Volume 5,131
  • Avg. Volume 3,211
  • Market Cap (intraday) 432.356M
  • Beta (5Y Monthly) 0.19
  • PE Ratio (TTM) 3.16
  • EPS (TTM) 19.62
  • Earnings Date --
  • Forward Dividend & Yield 2.80 (4.51%)
  • Ex-Dividend Date May 28, 2025
  • 1y Target Est --

DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company also provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skin care; and beauty products and services. The company was founded in 2011 and is based in Taipei, Taiwan.

www.dvbiomed.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6539.TWO

View More

Performance Overview: 6539.TWO

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6539.TWO
0.32%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
13.87%

1-Year Return

6539.TWO
50.31%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.98%

3-Year Return

6539.TWO
86.03%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
16.68%

5-Year Return

6539.TWO
73.20%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
89.91%

Compare To: 6539.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6539.TWO

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    433.05M

  • Enterprise Value

    190.66M

  • Trailing P/E

    3.16

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.13

  • Price/Book (mrq)

    0.87

  • Enterprise Value/Revenue

    0.13

  • Enterprise Value/EBITDA

    0.56

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.30%

  • Return on Assets (ttm)

    6.21%

  • Return on Equity (ttm)

    14.02%

  • Revenue (ttm)

    1.46B

  • Net Income Avi to Common (ttm)

    52.67M

  • Diluted EPS (ttm)

    19.62

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    274.59M

  • Total Debt/Equity (mrq)

    6.47%

  • Levered Free Cash Flow (ttm)

    -101.52M

Research Analysis: 6539.TWO

View More

Company Insights: 6539.TWO

Research Reports: 6539.TWO

View More

People Also Watch